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A B S T R A C T
Background: Previous pathohistological studies demonstrated that cholesterol crystals (CCs) are
frequently observed in atherosclerotic plaques, and are usually present abundantly in vulnerable
plaques. However, the role of CCs in plaque destabilization, as well as their origin and composition, is
unknown. Optical coherence tomography (OCT) imaging system is a high-resolution imaging device,
which allows the in vivo identiﬁcation of CCs accumulating within atherosclerotic plaques. The aim of
this study was to investigate the relationship between the presence of CCs, other plaque morphologies
assessed by OCT, and patients’ clinical characteristics including acute coronary syndrome (ACS).
Methods and results: Preinterventional OCT images of 173 patients with either ACS or stable angina
pectoris were studied. Of 173 lesions in the patients, 66 (38%) had CCs within the culprit lesion segment
and 107 (62%) had non-CC lesions. Multivariate analysis revealed that low high-density lipoprotein
cholesterol levels, diabetes mellitus, the presence of plaque rupture, intimal vasculature, and thrombus
were independent factors associated with CCs. Moreover, the frequency of CCs increased in proportion to
the accumulation of the number of components of their vulnerable plaque features within the culprit
lesion segment. Compared with the plaques without thrombus, CCs were present at shallower locations
in those with thrombus.
Conclusions: This study demonstrates the potential correlation between the clinical metabolic disorder
and vulnerable morphological features of culprit lesions to the presence of CCs in patients with stable
and unstable coronary syndromes. These observations of CCs by using in vivo plaque imaging could
provide incremental value to OCT evaluation of atherosclerotic plaques.
 2016 The Authors. Published by Elsevier Ltd on behalf of Japanese College of Cardiology. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Culprit plaque morphology in patients with acute coronary
syndromes (ACS) varies from thrombosis with or without plaque
rupture to sudden narrowing of the lumen from intraplaque
hemorrhage [1]. The early detection of vulnerable plaques is
necessary to prevent ACS. For instance, a large lipid-pool, thin
ﬁbrous cap, and macrophage accumulation have been considered
as vulnerable features [2]. Previous pathohistological studies* Corresponding author at: Department of Cardiovascular Medicine, Osaka City
University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka
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creativecommons.org/licenses/by-nc-nd/4.0/).demonstrated that cholesterol crystals (CCs) are frequently found
in atherosclerotic plaques and are usually abundant in vulnerable
plaques [3]. However, the role of CCs in plaque destabilization, as
well as their origin and composition, is unknown.
Previous pathological studies by Abela et al. demonstrated that
CCs could cause plaque rupture by mechanically protruding the
ﬁbrous cap and inducing thrombus formation. These studies have
shown that individual CCs measured by scanning electron
microscopy were 1–3 mm in diameter at the tips, 50–150 mm
long, and up to 20 mm wide at the base [3]. Therefore, intravascular
ultrasound images could not visualize individual CCs due to lack of
spatial resolution. The optical coherence tomography (OCT)
imaging system is a high-resolution imaging device that provides
a maximal axial resolution of 10 mm, which allows the in vivo
identiﬁcation of not only plaque rupture, ﬁbrous cap thickness, andof Cardiology. This is an open access article under the CC BY-NC-ND license (http://
Fig. 1. Measurement of the minimum depth from the lumen surface to the leading
edge for the shallowest cholesterol crystal within the culprit lesion segment.
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lature, and structures suggestive of CC accumulation within
atherosclerotic plaques [4–7].
Thus, to date, to the best of our knowledge, few studies have
investigated the relationship between the presence of CCs, other
plaque morphologies assessed by OCT, and clinical characteristics
in patients with stable and unstable coronary syndromes. The
present study has been designed for this purpose.
Material and methods
Study population
From September 2011 to March 2015, 190 consecutive patients
with either ACS or stable angina pectoris (SAP), who underwent
OCT examination on a native de novo culprit lesion prior to
percutaneous coronary intervention (PCI) at the Osaka City
University, were enrolled in this study. Patients with congestive
heart failure, cardiogenic shock, and who underwent prior PCI or
coronary artery bypass grafting were excluded from the study. Of
the 190 patients initially enrolled, 17 were excluded for technical
reasons; 13 patients did not undergo OCT examination before PCI
because of unsuccessful reperfusion to Thrombolysis in Myocardial
Infarction (TIMI) ﬂow grade 3 by initial aspiration thrombectomy
before imaging (n = 5) and failure to advance the OCT catheter to
the culprit lesion (n = 8), and 4 patients had poor OCT images that
were too low-quality to allow analysis.
Taking into account intra-patient correlations when evaluating
the data, one culprit lesion was used for analysis of patients with
more than 2 lesions. Thus, 173 lesions from 173 patients with
either ACS or SAP, who had documented narrowing of at least 50%
of the luminal diameter of a major coronary artery on coronary
angiography (CAG), were examined in this study. Among the ACS
patients, 112 had either acute myocardial infarction or unstable
angina pectoris (UAP). Fifteen patients had acute myocardial
infarction. The diagnosis was based on prolonged ischemic
discomfort, characteristic electrocardiographic changes, and ele-
vation of myocardial enzyme levels. UAP was diagnosed in
97 patients. UAP was deﬁned either as new onset angina within
2 months after a previous ischemic event; as angina with a
progressive crescendo pattern, with the angina episodes increasing
in frequency and/or duration; or as angina that occurred at rest,
according to Braunwald’s criteria. The other SAP group included
61 patients with chest pain typical of cardiac ischemia on exertion
that was clinically unchanged for >2 months. Oral aspirin (100 mg)
and clopidogrel (300 mg loading dosage, 75 mg/day) or prasugrel
(20 mg loading dosage, 3.75 mg/day) were administered on
admission. Patients at high risk were also treated with intravenous
heparin, but no patient was administered thrombolytic agents.
The following data were also collected: age, sex, and presence of
risk factors [smoking and hypertension, as deﬁned by the Joint
National Committee VII; diabetes mellitus, as deﬁned by the World
Health Organization (WHO) Study Group; or dyslipidemia, as
deﬁned by the Japan Atherosclerosis Society Guidelines]. More-
over, high-density lipoprotein (HDL) cholesterol levels were
categorized as either <35 mg/dL or 35 mg/dL, according to a
previous report [8].
The study was approved by the hospital ethics committee, and
informed consent was obtained from all patients before the study.
OCT image acquisition
OCT imaging was performed for the culprit vessel before
intervention, after administration of 0.2 mg of intracoronary
nitroglycerin. The culprit vessel was identiﬁed based on clinical,
scintigram stress test, and angiographic data. In patients with TIMIﬂow grade  2, aspiration thrombectomy was performed using an
aspiration catheter (Thrombuster II, Kaneka Medical Products,
Osaka, Japan) before OCT imaging, but predilation using a balloon
catheter was not performed. After reperfusion was gained with
TIMI ﬂow grade 3, OCT images were acquired using a time-domain
(M2CV OCT Imaging System; LightLab Imaging, Westford, MA,
USA), or a frequency-domain (C7-XR OCT Intravascular Imaging
System; St Jude Medical, St Paul, MN, USA) OCT system; or an
optical frequency-domain imaging (OFDI) device (Terumo OFDI
system; Terumo Corporation, Tokyo, Japan). The intracoronary OCT
imaging technique has been described previously [9,10].
OCT image analysis
The culprit lesion site selected for analysis was the image slice
with the minimal lumen area. A 10-mm-long culprit lesion
segment (5 mm proximal and 5 mm distal to the culprit lesion
site) was used for the assessment of plaque morphology, in
accordance with previous reports [11].
OCT image analysis was performed, using previously estab-
lished criteria for OCT plaque characterization [4–7], by 2 experi-
enced observers who were blinded to the clinical information. In
the case of discordance of diagnosis between the 2 observers, a
consensus diagnosis was obtained using repeated off-line readings.
The presence of CCs, plaque rupture, lipid-rich plaque, thin-cap
ﬁbroatheroma (TCFA), macrophage accumulation, intimal vascu-
lature, intracoronary thrombus, and calciﬁcation were evaluated.
CC was deﬁned as thin and linear structures with high
backscattering without attenuation within the plaque. For the
shallowest CC within the culprit lesion segment, the minimum
depth from the lumen surface to the leading edge was also
measured (Fig. 1). Plaque rupture was deﬁned as an intimal
interruption and cavity formation in the plaque. A plaque having
lipids characterized by signal-poor regions with diffuse borders
and present in over 908 in any of the cross-sectional images within
a plaque was considered a lipid-rich plaque. TCFA was deﬁned as a
lipid-rich plaque with a ﬁbrous cap thickness measuring 65 mm.
Macrophage accumulation was deﬁned as bright spots with high
OCT backscattering signal variances. Intimal vasculature was
deﬁned as a black hole or a tubular structure within a plaque.
Thrombus was identiﬁed as an irregular high- or low-backscatter-
ing mass protruding into the lumen. Calciﬁcation was deﬁned as
well-delineated, signal-poor regions with sharp borders. The
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k statistic for each plaque characterization detected by OCT were
also reported in our previous study [11]. The k-values for
interobserver and intraobserver agreements on the presence of
CCs within the 10-mm-long culprit lesion segment were 0.86 and
0.89, respectively.
Statistical analysis
Continuous data are presented as mean  SD or median and
interquartile range for non-normally distributed data. Continuous
variables were compared using either the Student’s t-test or the
nonparametric Wilcoxon rank-sum test for non-normally distributed
variables. Categorical variables were compared using the x2 test.
Concordance between investigators was assessed by k statistics.
Multivariate logistic regression analyses were performed to identify
independent predictors of CCs. Variables identiﬁed at univariate
analysis with a p-value < 0.05 and of clinical importance regarding
metabolic disorder [low-density lipoprotein (LDL), HDL cholesterol
levels, statin use, and diabetes mellitus] were entered into the
multivariate model. Differences were considered signiﬁcant at
p < 0.05. Statistical analysis was performed using JMP, version
13 for Windows (SAS Institute, Cary, NC, USA).
Results
OCT and OFDI were performed in all patients without any
serious complications. All patients were divided into 2 groups
according to the presence of CCs within the culprit lesion segment:
CCs (n = 66) and non-CCs (n = 107). All analyses were performed
comparing these 2 groups.
Table 1 shows the baseline clinical characteristics in patients
with and without CCs. Of the 173 lesions from 173 patients, 66




Age (years) 69  10 
Male, n (%) 55 (83%) 
Body mass index (kg/m2) 23.9  3.4 
Risk factor
Hypertension, n (%) 52 (79%) 
Dyslipidemia, n (%) 44 (67%) 
LDL cholesterol (mg/dL) 112.3  35.7 
HDL cholesterol (mg/dL) 40.3  10.7 
HDL cholesterol <35 mg/dL, n (%) 21 (32%) 
Statin use, n (%) 24 (36%) 
Diabetes mellitus, n (%) 38 (58%) 
Hemoglobin A1c (%) 6.4  1.5 
Smoking (%) 42 (64%) 
eGFR (mL/min/1.73 m2) 63.3  22.2 
eGFR <60 mL/min/1.73 m2, n (%) 24 (36%) 
hs-CRP (mg/dL) 0.12 (0.05–0.31) 
Diagnosis 
ACS, n (%) 50 (76%) 
AMI 8 (12%) 
UAP 42 (64%) 
SAP, n (%) 16 (24%) 
Culprit vessel 
LAD, n (%) 37 (56%) 
LCX, n (%) 12 (18%) 
RCA, n (%) 17 (26%) 
Thrombectomy before imaging 5 (7.6%) 
Values are mean  SD, number of patients (percentage), or median (25th to 75th perce
CC, cholesterol crystal; LDL, low-density lipoprotein; HDL, high-density lipoprotein; eGFR, 
acute coronary syndrome; AMI, acute myocardial infarction; UAP, unstable angina pectori
circumﬂex coronary artery; RCA: right coronary artery.non-CC lesions. The frequency of ACS was signiﬁcantly higher in CC
lesions than in non-CC lesions (p = 0.022). No signiﬁcant differ-
ences were found in age, gender, body mass index, risk factors,
statin use, estimated glomerular ﬁltration rate, high-sensitivity
C-reactive protein, culprit vessel, or thrombectomy procedure
before OCT imaging between the 2 groups.
The relationship between CCs/non-CCs and plaque morphology
assessed by OCT is shown in Table 2. CCs were observed more
frequently by OFDI and less frequently by C7 than non-CCs. In CC
lesions, the frequencies of plaque rupture (p = 0.001), TCFA
(p = 0.002), macrophage accumulation (p = 0.015), intimal vascu-
lature (p = 0.028), and thrombus (p = 0.005) were higher than in
non-CC lesions. Neither the lipid-rich plaque nor the calciﬁcation
between CC and non-CC lesions showed any signiﬁcant differences.
To identify the independent factors associated with CCs, a
multivariate logistic regression analysis was performed using the
following parameters identiﬁed at univariate analysis with a
p-value < 0.05: ACS, plaque rupture, TCFA, macrophage, intimal
vasculature, and thrombus (Table 3, model 1). Multivariate
analysis revealed that plaque rupture and intimal vasculature
were independent factors associated with CCs. Subsequently, each
metabolic disorder variable, such as LDL cholesterol levels, HDL
cholesterol levels less than 35 mg/dL, statin use, and diabetes
mellitus, was inserted into different models (model 2–5). Finally,
considering the correlation between them, model 6 showed that
HDL cholesterol levels less than 35 mg/dL and diabetes mellitus, as
well as plaque rupture, intimal vasculature, and thrombus,
remained independent factors associated with CCs. Fig. 2 shows
the correlation between the frequency of CCs and the number of
vulnerable plaque features, namely, plaque rupture, intimal
vasculature, and thrombus within the culprit lesion segment. Of
the 173 lesions, 27 (16%) had 2 features within the culprit lesion
segment, 69 (40%) had 1 feature, and 77 (44%) had no vulnerable
plaque features. The frequency of CCs increased in proportion toNon-CCs
(n = 107)
p value
67  10 0.25
86 (80%) 0.69
23.1  3.6 0.15
81 (76%) 0.71
73 (68%) 0.87
105.3  31.7 0.18




6.2  1.1 0.16
63 (59%) 0.63














estimated glomerular ﬁltration rate; hs-CRP, high-sensitivity C-reactive protein; ACS,
s; SAP, stable angina pectoris; LAD, left anterior descending coronary artery; LCX, left
Table 2







M2 7 (10.6%) 10 (9.3%)
C7 30 (45.5%) 74 (69.2%)
OFDI 29 (43.9%) 23 (21.5%)
Minimal lumen area (mm2) 1.34  0.86 1.54  0.72 0.085
Plaque rupture, n (%) 21 (31.8%) 11 (10.3%) 0.001
Lipid-rich plaque, n (%) 49 (74.2%) 69 (64.5%) 0.239
TCFA, n (%) 17 (25.8%) 8 (7.5%) 0.002
Macrophage, n (%) 50 (75.8%) 61 (57.0%) 0.015
Intimal vasculature, n (%) 28 (42.4%) 27 (25.2%) 0.028
Thrombus, n (%) 23 (34.8%) 17 (15.9%) 0.005
Calciﬁcation, n (%) 35 (53.0%) 62 (57.9%) 0.533
Values are mean  SD or number of patients (percentage).
OCT, optical coherence tomography; CC, cholesterol crystal; OFDI, optical
frequency-domain imaging; TCFA, thin-cap ﬁbroatheroma.
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Furthermore, among patients (n = 66) with CC, the minimum depth
of CC from the luminal surface was signiﬁcantly smaller in the
plaques with thrombus (n = 23) than in those without thrombus
(n = 43) (with thrombus, 131  78; without thrombus,
221  181 mm; p < 0.05) (Fig. 3).
A representative case of a CC lesion assessed by OCT is shown in
Fig. 4. OCT shows CCs surrounding plaque rupture, intimal
vasculature, and thrombus.
Discussion
To the best of our knowledge, this is the ﬁrst study to report the
factors associated with CCs in patients with stable and unstable
coronary syndromes.
Although recently, some studies have focused on the associa-
tion between the presence of CCs and ACS [3,6,7,12,13], theirTable 3
Multivariate logistic regression analysis for CCs.
Model 1 
OR 95%CI p value OR
ACS 1.66 0.79–3.55 0.181 1.59
Plaque rupture 2.94 1.15–7.68 0.024 2.95
TCFA 2.55 0.92–7.41 0.072 2.60
Macrophage 1.67 0.78–3.66 0.184 1.64
Intimal vasculature 2.47 1.20–5.17 0.015 2.44
Thrombus 2.32 0.99–5.43 0.052 2.31
LDL-cholesterol – – – 1.00
HDL-cholesterol < 35 mg/dL – – – – 
Statin use – – – – 
Diabetes mellitus – – – – 
Model 4 
OR 95%CI p value OR
ACS 1.49 0.70–3.23 0.302 1.95
Plaque rupture 2.73 1.06–7.15 0.037 2.75
TCFA 2.89 1.02–8.68 0.045 2.52
Macrophage 1.69 0.79–3.73 0.178 1.66
Intimal vasculature 2.72 1.30–5.84 0.008 2.62
Thrombus 2.72 1.13–6.64 0.025 2.63
LDL-cholesterol – – – – 
HDL-cholesterol < 35 mg/dL – – – – 
Statin use 0.54 0.25–1.14 0.106 – 
Diabetes mellitus – – – 2.36
CC, cholesterol crystal; OR, odds ratio; CI, conﬁdence interval; ACS, acute coronary sy
density lipoprotein.potential role in plaque disruption has not been fully elucidated.
An autopsy study demonstrated strong associations between CCs
and plaque disruption, thrombus, symptoms, and plaque size [3].
A recent OCT study by Nakamura et al. showed close association of
the presence of CCs with lipid-rich plaques, spotty calciﬁcation,
and intimal vasculature, although the frequencies of thrombus,
rupture, and TCFA did not differ signiﬁcantly between patients
with SAP having CCs or no CCs [6]. Moreover, Kataoka et al.
reported that culprit plaques with CCs exhibited larger lipid arcs
and a greater frequency of TCFA in patients with SAP [7]. However,
culprit lesions in only patients with SAP were examined in that
study, both patients with SAP and with ACS were included in the
present study. Nevertheless, the previous pathohistological and
OCT data, together with our present ﬁndings based on patients
with coronary artery diseases including ACS, support the conclu-
sion that the presence of CCs was associated with coronary
vulnerable plaque morphology.
On considering the clinical characteristics, diabetes mellitus
and lower HDL cholesterol levels were associated with CCs. The
inﬂuence of diabetes mellitus and HDL cholesterol on CCs was
compatible with previous reports [6,14]. Epidemiological studies
suggest that patients with diabetes mellitus have increased
prevalence of coronary artery disease, and increased relative risk
of ACS. Patients with diabetes mellitus have more vulnerable
plaques than those without [15,16]. Among the many risk factors
for atherogenesis in patients with diabetes, previous studies have
focused on the inﬂammation induced by increased advanced
glycation end products formation, which may activate macro-
phages and increase oxidative stress [17]. Nakamura et al. showed
that glucose intolerance may play an important role in CC
formation in coronary plaques [6]. In contrast, lower HDL
cholesterol levels seem to be associated with a greater plaque
burden, increased plaque rupture, and a higher risk of cardiovas-
cular events, even among patients with normal LDL cholesterol
levels, including those who were treated with statins [18,19]. HDL
cholesterol has antioxidant and anti-inﬂammatory effects, and
facilitates macrophage cholesterol efﬂux [20]. Moreover, in vitro,Model 2 Model 3
 95%CI p value OR 95%CI p value
 0.75–3.42 0.224 1.91 0.89–4.20 0.096
 1.15–7.78 0.024 3.21 1.25–8.46 0.015
 0.94–7.58 0.066 2.39 0.85–7.10 0.101
 0.77–3.60 0.203 1.84 0.85–4.14 0.123
 1.18–5.12 0.016 2.82 1.33–6.12 0.007
 0.99–5.43 0.052 2.27 0.97–5.39 0.060
 0.99–1.02 0.382 – – –
– – 2.92 1.28–6.88 0.011
– – – – –
– – – – –
Model 5 Model 6
 95%CI p value OR 95%CI p value
 0.91–4.30 0.087 1.96 0.88–4.53 0.102
 1.08–7.21 0.033 2.80 1.08–7.57 0.035
 0.90–7.44 0.078 2.85 0.98–8.76 0.055
 0.77–3.68 0.197 1.88 0.84–4.39 0.127
 1.25–5.59 0.011 3.22 1.47–7.30 0.003
 1.11–6.32 0.029 3.31 1.31–8.61 0.011
– – 1.01 0.99–1.02 0.229
– – 2.97 1.22–7.53 0.017
– – 0.50 0.22–1.12 0.093
 1.16–4.93 0.018 2.72 1.27–6.08 0.010
ndrome; TCFA, thin-cap ﬁbroatheroma; LDL, low-density lipoprotein; HDL, high-
Fig. 2. Correlation between the frequency of cholesterol crystals (CCs) and the number of vulnerable plaque features, namely, plaque rupture, intimal vasculature, and
thrombus within the culprit lesion segment.
S. Nishimura et al. / Journal of Cardiology 69 (2017) 253–259 257CCs are destroyed by incubation with HDL cholesterol [21].
Niyonzima et al. demonstrated that reconstituted HDL cholesterol
bound to CCs inhibited the CC-induced complement activation,
and attenuated the amount of CC-induced complement receptor
expression on inﬂammatory cells [14]. These experimental data
suggest the potential role of hyperglycemia and lower HDL
cholesterol levels in CC formation within coronary plaques via
cholesterol metabolism and inﬂammatory conditions.
CCs are a common ﬁnding in human coronary arteries, which
have been long considered as relatively inert. CCs are formed either
from the free cholesterol of cell membranes or from the cholesterol
esters hydrolyzed in macrophage lysosomes within atherosclerotic
plaques [22]. Kolodgie et al. showed that glycophorin A and iron
are co-localized with CCs in the atherosclerotic lesions and
hypothesized that CCs could originate from the erythrocytes
phagocytized by macrophages [23]. The direct relationship
between erythrocyte extravasation from plaque vasculature and
the formation of CCs was then replicated by Lin et al. [24]. Abela
et al. also developed a new insight into CCs, demonstrating that the
crystallization of cholesterol from liquid to a solid state resulted in
volume expansion and that increasing amount of crystal content
was signiﬁcantly associated with a larger plaque size [3,12]. They
also showed that CCs during dynamic volume expansion withFig. 3. Among patients with cholesterol crystals (CCs), the minimum depth of CC
from the luminal surface between the plaques with and without thrombus.crystallization had the potential to disrupt and perforate the
plaque cap emerging onto the intimal surface with subsequent
thrombus formation in vivo [3,12]. The present study demonstrat-
ed that the greater the number of features of vulnerable plaques,
such as plaque rupture, intimal vasculature, and thrombus, the
higher the frequency of CCs. Furthermore, CCs in the plaques with
thrombus were in shallower locations than in those plaques
without thrombus. CCs are present not only in advanced plaques
but also in nascent atherosclerotic plaques [25,26]. In general, CC
formation itself is considered a part of the process of atheroscle-
rosis, but its process is different from the acute progression
following plaque rupture. Therefore, we should take account of not
only the presence of CC, but also of its surrounding environment,
such as more vulnerable plaque morphology, as eventually these
factors combined may lead to ACS.
What is the clinical relevance of identifying CCs in human
atherosclerotic lesions? Accumulating evidence has shown that an
atherosclerotic disease is a chronic inﬂammatory process with the
involvement of many arterial segments, despite the fact that a
single localized culprit lesion may cause an acute syndrome.
Therefore, the problem is to identify such additional ‘‘vulnerable’’
sites. OCT is acknowledged as one of the most reliable tools for the
assessment of coronary plaque characterization, and our observa-
tions on CCs could be of help in discerning ‘‘stable’’ from ‘‘unstable’’
sites. At this point, the presence of CCs as an indication either of
vulnerable plaques or of a trigger of plaque destabilization remains
unknown. Interestingly, Abela et al. reported that CC density was
markedly decreased and appeared dissolved in human plaques
incubated with statins [13], although the frequency of statin use
did not differ between the CC and non-CC groups in the present
study. In future, CC might be potential therapeutic targets to
prevent cardiovascular events.
Study limitations
The present study had several limitations. First, OCT examina-
tion was done with three types of devices (M2, C7, and OFDI). A
difference in the ability of penetration depth of each device-
scanning beam was possible. However, this was not evident;
therefore, further investigations are required. Second, the frequen-
cy of CCs within more vulnerable lesions might be underestimated
Fig. 4. A representative case of optical coherence tomography images of a cholesterol crystal (CC) lesion surrounding plaque rupture, intimal vasculature, and thrombus.
(A and B) Culprit lesion with a large thrombus (arrows). (C–H) Proximal site of culprit lesion with CCs (arrowheads) surrounding plaque rupture (asterisks) and intimal
vasculature (circle).
S. Nishimura et al. / Journal of Cardiology 69 (2017) 253–259258because the OCT-scanning beam was attenuated by lipid and
thrombus. In the present study, however, CCs in the plaques with
thrombus were shallower, than in those without thrombus. As the
most important morphological determinants of plaque vulnera-
bility are superﬁcial, the region of greatest interest was still within
the imaging range of the current OCT system. Therefore, we
consider the quality of these OCT data to be sufﬁciently high to
validate our conclusion. Third, aspiration thrombectomy was
performed before OCT imaging in some patients with AMI.
Although the morphologic feature of the culprit lesion might be
affected by this procedure, no signiﬁcant difference was found in
that frequency between patients with and without CCs. In addition,
imaging before treatment would not be appropriate ethically and
technically. Last, patients without an OCT examination before PCI
owing to crossing failure were excluded from this study. Therefore,
our results were limited by selection bias and they may not be
applicable to such patients.
Conclusions
This study demonstrates that the clinical metabolic disorder
and vulnerable morphological features of culprit lesions could be
related to the presence of CCs in patients with stable and unstable
coronary syndromes. These observations of CC by using in vivo
plaque imaging could provide incremental value to OCT evaluation
of atherosclerotic plaques, and may inﬂuence the treatment
strategies in future.
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